
The Pepper Foundation: Seba Quezada Berko Fun Run pepper.enthuse.com/pf/sebast…

Follow the data trail

The Pepper Foundation: Seba Quezada Berko Fun Run pepper.enthuse.com/pf/sebast…


Absolutely honoured to be elected Fellow of the Academy of Medical Sciences together with amazing @ucl colleagues!! Thanks to @uclcancer @CR_UK and my amazing team @QuezadaLab ucl.ac.uk/news/2024/may/ucl-…

Congratulations to Professors Christopher Denton @IIT_UCL, Alison Rodger @UCLGlobalHealth, @Mayor_lab @UCLBiosciences & @SQuezadd @UCLCancer on their election as Fellows to @AcMedSci in recognition of their outstanding contributions to biomedical research ucl.ac.uk/news/2024/may/ucl-…

Supernice paper on cis-targeted IL-2 therapy for chronic HBV from @iannaconelab @ScienceTM!
💥 New Publication Alert in @ScienceTM! Excited to share our latest breakthrough in tackling chronic #hepatitis B virus (#HBV) with a novel cis-targeted IL-2 therapy. 🧪 science.org/doi/10.1126/scit… 🧵(1/11)

⏰ Time for a review! Dr. @squezadd and team discuss the current understanding of the contribution of FcγRs to the in vivo activity of immunomodulatory antibodies, and the challenges of translating results from preclinical models into the clinic. 🏥 go.nature.com/3Reej3D

Muchísimas gracias @mdeambrosio por esta editorial que me emocionó muchísimo. Gracias a tanta gente que ha trabajado y sigue apostando a que este sueño se haga realidad y permita dar muchísimas mas oportunidades, fundamentalmente a pacientes. lanacion.com.ar/sociedad/gab…


CONIPHER, our method for automated reconstruction of tumour subclonal structure and phylogeny that we used in our recently published TRACERx studies, is now out in Nature Protocols! (nature.com/articles/s41596-0…). Welcome to the CONIPHER TREEtorial, just in time for Christmas! 🌲 1/n

Dr Aurélien Marabelle @GustaveRoussy announces Dr Steven A. Rosenberg recipient ESMO Immuno-Oncology Award! #ESMOimmuno23 @myESMO @NCI_CCR_SB @NCIResearchCtr @NCItreatment @NCIDirector /notes Dr Eric Tran’s & @romleidner’s work @ChilesResearch of TCR KRAS #immunotherapy @NEJM

❕ Don't miss a new, very well-written @ImmunityCP review! Authors @EGhoranil, @squezadd & @CharlesSwanton discuss cancer cell-intrinsic mechanisms driving acquired #ImmuneTolerance. 📘 shorturl.at/CMOPT

@crispinhiley presenting results from Darwin2 TRACERx prospective trial Clonal TMB associated with durable clinical benefit and transcriptomic intratumour heterogeneity with worse outcome @CRUKresearch @uclcancer @TheCrick @CRUKLungCentre

Really cool work to be presented by the @achillestx team based on our collaboration with teams @uclcancer, @samuels_yardena @CharlesSwanton @Marcrmansour and the Hadrup Lab
Excited to present our first DECOD-Ag poster at CICON23! 🎉 Looking forward to sharing our research on predicting neoantigen immunogenicity and connecting with fellow attendees. #CICON23 #neoantigens Great collab with @ucl, @TheCrick, @DTUtweet, @WeizmannScience and @achillestx.

Excited to present our first DECOD-Ag poster at CICON23! 🎉 Looking forward to sharing our research on predicting neoantigen immunogenicity and connecting with fellow attendees. #CICON23 #neoantigens Great collab with @ucl, @TheCrick, @DTUtweet, @WeizmannScience and @achillestx.

This Friday, catch our Prof. Sergio Quezada and other key leaders of the field of Cancer Immunotherapy discussing all things Tregs from fundamental to translational research. Follow the link below to register. shorturl.at/eqw26

Great opportunity for a talented postdoc to work between our labs!
Join us! A postdoc position between my lab and @QuezadaLab has become available at @uclcancer in London. Please help us characterise the molecular mechanisms through which anti-tumour immune responses are controlled. To apply ucl.ac.uk/work-at-ucl/search… Deadline 14 Sept Please RT!